Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yongkun Sun

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
Stem Cells International|November 20, 2025
Identification and Validation of a New Functional Gene <i>TSC22D3</i> for hBMSCs OsteogenesisShuhong Zhang, Xiao Li, Zhanping Yang, et al.
Frontiers in Endocrinology|September 23, 2024
Survival prediction in peritoneal mesothelioma: a nomogram based on SEER data and a Chinese cohortYuting Fang, Midan Xiang, Zhichao Jiang, et al.
Frontiers in Oncology|December 7, 2020
Longitudinal Pharmacometabonomics for Predicting Malignant Tumor Patient Responses to Anlotinib Therapy: Phenotype, Efficacy, and ToxicityTing Hu, Zhuoling An, Yongkun Sun, et al.
Asia-Pacific Journal of Clinical Oncology|January 24, 2023
Less aggressive treatment for less aggressive disease? A retrospective single-center study of pulmonary-limited metastases associated with colorectal cancerWang Qu, Yongkun Sun, Wen Zhang, et al.
Toxicology Mechanisms and Methods|February 10, 2012
Stevioside enhances apoptosis induced by serum deprivation in PC12 cellsKumiko Takahashi, Yongkun Sun, Ikumi Yanagiuchi, et al.
Frontiers in Oncology|April 19, 2024
FOLFOXIRI plus cetuximab as conversion therapy for unresectable RAS/BRAF wild-type left-sided colorectal cancer with liver-limited metastases: a prospective dual-center pilot studyWenwei Yang, Dong Chen, Yaru Niu, et al.
Asia-Pacific Journal of Clinical Oncology|January 30, 2019
Outcome of chemotherapy with or without targeted agents in metastatic colorectal cancer patients with deficient DNA mismatch repair: A single center, cohort studyYue Yu, Jianming Ying, Wen Zhang, et al.
Cancer Chemotherapy and Pharmacology|July 29, 2018
Nab-paclitaxel plus S-1 as first-line followed by S-1 maintenance for advanced pancreatic adenocarcinoma: a single-arm phase II trialWen Zhang, Chunxia Du, Yongkun Sun, et al.
BMC Cancer|May 11, 2018
Phase II study of adjuvant chemotherapy with S1 plus oxaliplatin for Chinese patients with gastric cancerGuoxiu Wang, Jiuda Zhao, Yan Song, et al.
Cancer Management and Research|August 16, 2021
The Real-World Practice of Fruquintinib for Chinese Patients with Metastatic Colorectal CancerYan Song, Tao Qu, Honggang Zhang, et al.
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
Stem Cells International|November 20, 2025
Identification and Validation of a New Functional Gene <i>TSC22D3</i> for hBMSCs OsteogenesisShuhong Zhang, Xiao Li, Zhanping Yang, et al.
Frontiers in Endocrinology|September 23, 2024
Survival prediction in peritoneal mesothelioma: a nomogram based on SEER data and a Chinese cohortYuting Fang, Midan Xiang, Zhichao Jiang, et al.
Frontiers in Oncology|December 7, 2020
Longitudinal Pharmacometabonomics for Predicting Malignant Tumor Patient Responses to Anlotinib Therapy: Phenotype, Efficacy, and ToxicityTing Hu, Zhuoling An, Yongkun Sun, et al.
Asia-Pacific Journal of Clinical Oncology|January 24, 2023
Less aggressive treatment for less aggressive disease? A retrospective single-center study of pulmonary-limited metastases associated with colorectal cancerWang Qu, Yongkun Sun, Wen Zhang, et al.
Toxicology Mechanisms and Methods|February 10, 2012
Stevioside enhances apoptosis induced by serum deprivation in PC12 cellsKumiko Takahashi, Yongkun Sun, Ikumi Yanagiuchi, et al.
Frontiers in Oncology|April 19, 2024
FOLFOXIRI plus cetuximab as conversion therapy for unresectable RAS/BRAF wild-type left-sided colorectal cancer with liver-limited metastases: a prospective dual-center pilot studyWenwei Yang, Dong Chen, Yaru Niu, et al.
Asia-Pacific Journal of Clinical Oncology|January 30, 2019
Outcome of chemotherapy with or without targeted agents in metastatic colorectal cancer patients with deficient DNA mismatch repair: A single center, cohort studyYue Yu, Jianming Ying, Wen Zhang, et al.
Cancer Chemotherapy and Pharmacology|July 29, 2018
Nab-paclitaxel plus S-1 as first-line followed by S-1 maintenance for advanced pancreatic adenocarcinoma: a single-arm phase II trialWen Zhang, Chunxia Du, Yongkun Sun, et al.
BMC Cancer|May 11, 2018
Phase II study of adjuvant chemotherapy with S1 plus oxaliplatin for Chinese patients with gastric cancerGuoxiu Wang, Jiuda Zhao, Yan Song, et al.
Cancer Management and Research|August 16, 2021
The Real-World Practice of Fruquintinib for Chinese Patients with Metastatic Colorectal CancerYan Song, Tao Qu, Honggang Zhang, et al.
Pageof 8